N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography

Clinical trial NCT00830193 · COMPLETED

Trial details

NCT number: NCT00830193
Sponsor: Unity Health Toronto
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Contrast Induced Nephropathy Critically Ill

Start date: 2002-08-01
Primary completion: 2005-05-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.